Robecosam AG purchased a new position in shares of Maximus, Inc. (NYSE:MMS) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 119,230 shares of the health services provider’s stock, valued at approximately $7,486,000. Robecosam AG owned 0.18% of Maximus as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently bought and sold shares of the stock. Ameritas Investment Partners Inc. boosted its holdings in shares of Maximus by 2.1% during the second quarter. Ameritas Investment Partners Inc. now owns 25,038 shares of the health services provider’s stock worth $1,568,000 after purchasing an additional 517 shares during the period. Nomura Holdings Inc. acquired a new stake in shares of Maximus during the second quarter worth approximately $636,000. The Manufacturers Life Insurance Company boosted its holdings in shares of Maximus by 0.9% during the second quarter. The Manufacturers Life Insurance Company now owns 142,402 shares of the health services provider’s stock worth $8,919,000 after purchasing an additional 1,279 shares during the period. Makaira Partners LLC boosted its holdings in shares of Maximus by 6.3% during the second quarter. Makaira Partners LLC now owns 143,153 shares of the health services provider’s stock worth $8,966,000 after purchasing an additional 8,480 shares during the period. Finally, Cubist Systematic Strategies LLC boosted its holdings in shares of Maximus by 16.0% during the second quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock worth $249,000 after purchasing an additional 546 shares during the period. Institutional investors and hedge funds own 97.23% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Robecosam AG Purchases New Holdings in Maximus, Inc. (MMS)” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/10/13/robecosam-ag-purchases-new-holdings-in-maximus-inc-mms.html.
MMS has been the subject of several research reports. Zacks Investment Research upgraded shares of Maximus from a “hold” rating to a “buy” rating and set a $73.00 price target for the company in a report on Wednesday, October 4th. Robert W. Baird initiated coverage on shares of Maximus in a research note on Sunday, September 3rd. They issued a “neutral” rating for the company. BidaskClub cut shares of Maximus from a “strong-buy” rating to a “buy” rating in a research note on Thursday, July 6th. Maxim Group set a $66.00 target price on shares of Maximus and gave the company a “hold” rating in a research note on Thursday, August 3rd. Finally, Canaccord Genuity cut shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a research note on Tuesday, July 4th. One investment analyst has rated the stock with a sell rating and nine have assigned a hold rating to the stock. Maximus presently has a consensus rating of “Hold” and a consensus target price of $63.14.
Maximus, Inc. (NYSE MMS) traded up 0.11% during mid-day trading on Friday, reaching $65.34. 59,768 shares of the company’s stock were exchanged. The stock has a 50-day moving average price of $63.07 and a 200 day moving average price of $61.94. The company has a market cap of $4.24 billion, a PE ratio of 20.94 and a beta of 1.36. Maximus, Inc. has a 52-week low of $43.69 and a 52-week high of $66.38.
Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.79 EPS for the quarter, beating the consensus estimate of $0.76 by $0.03. The company had revenue of $600.40 million during the quarter, compared to the consensus estimate of $614.12 million. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The firm’s revenue for the quarter was down 2.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.79 EPS. Equities analysts predict that Maximus, Inc. will post $3.13 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th will be issued a $0.045 dividend. This represents a $0.18 annualized dividend and a dividend yield of 0.28%. The ex-dividend date of this dividend is Tuesday, November 14th. Maximus’s payout ratio is presently 5.73%.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).
What are top analysts saying about Maximus Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Maximus Inc. and related companies.